SCHEMBL10039495

SCHEMBL10039495

Cc1ccc(P(Oc2ccc(C(C)(C)C)cc2C(C)(C)C)Oc2ccc(C(C)(C)C)cc2C(C)(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.42
KDM4E B2RXH2 3/20 0.35
NR1I2 O75469 5/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
APEX1 P27695 1/20 0.33
MAPT P10636 4/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
ALDH1A1 P00352 2/20 0.31
RECQL P46063 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
MAPK1 P28482 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14606132 0.96 TSHR (0.39) TSHRKDM4ENR1I2CA1CA2
SCHEMBL9298561 0.94 CA1 (0.38) TSHRKDM4ECA1CA2CA9
SCHEMBL29939280 0.94 CA1 (0.38) TSHRKDM4ECA1CA2CA9
SCHEMBL13574881 0.92 CA1 (0.37) TSHRKDM4ENR1I2CA1CA2
SCHEMBL12861914 0.91 NR1I2 (0.34) TSHRKDM4ENR1I2CA1CA2
SCHEMBL13475623 0.91 NR1I2 (0.34) TSHRKDM4ENR1I2CA1CA2
SCHEMBL205802 0.89 CA1 (0.35) KDM4ECA1CA2CA9APEX1
SCHEMBL29355846 0.89 CA1 (0.35) KDM4ECA1CA2CA9APEX1
SCHEMBL9298566 0.86 PTGDR2 (0.38) KDM4ENR1I2CA1CA2CA9
SCHEMBL21922592 0.86 APEX1 (0.38) KDM4ECA1CA2CA9APEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240026124-A1 USE OF DIEUGENOL, OLIGOMERS AND/OR POLYMERS OF EUGENOL FOR STABILIZING ORGANIC MATERIALS, STABILIZED PLASTICS COMPOSITION, STABILIZER COMPOSITION AND METHOD FOR STABILIZING ORGANIC MATERIALS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2024-01-25 US disclosed
US-11760865-B2 Halogen-free sulphonic acid ester and/or sulphinic acid ester as flame retardant, flame retardant synergists and radical generators in plastics Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2023-09-19 US disclosed
US-9549881-B2 Stabilized dental impression composition, kit of parts and use thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2017-01-24 US disclosed
EP-2291562-B1 METHOD OF MAKING ELECTRET ARTICLES BASED ON ZETA POTENTIAL 3M INNOVATIVE PROPERTIES CO (US) 2017-01-04 EP disclosed
US-9193838-B2 High concentration pelletized additive concentrates for polymer INGENIA POLYMERS, INC. (US) 2015-11-24 US disclosed
US-9034218-B2 Cellulose ester film, method of manufacturing the same, polarizing plate and liquid crystal display KONICA MINOLTA OPTO, INC. (JP) 2015-05-19 US disclosed
US-9034218-B2 Cellulose ester film, method of manufacturing the same, polarizing plate and liquid crystal display KONICA MINOLTA OPTO, INC. (JP) 2015-05-19 US disclosed
US-8563625-B2 Hydrophilized curable silicone impression materials with improved storage behavior 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-10-22 US disclosed
US-8415414-B2 Polyurethane flame retardant compositions BASF SE (DE) 2013-04-09 US disclosed
US-20130041066-A1 HYDROPHILIZED CURABLE SILICONE IMPRESSION MATERIALS WITH IMPROVED STORAGE BEHAVIOR 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-02-14 US disclosed
US-20080057227-A1 Manufacturing method of cellulose acylate film, cellulose acylate film, polarizing plate and liquid crystal display KONICA MINOLTA OPTO, INC. (JP) 2008-03-06 US disclosed
US-20080057227-A1 Manufacturing method of cellulose acylate film, cellulose acylate film, polarizing plate and liquid crystal display KONICA MINOLTA OPTO, INC. (JP) 2008-03-06 US disclosed
US-20080043176-A1 Method of Manufacturing a Polarizing Plate Protective Film, Polarizing Plate Protective Film, Polarizing Plate, and Liquid Crystal Display Device KONICA MINOLTA OPTO, INC. (JP) 2008-02-21 US disclosed
US-20070254115-A1 Polarizer protective film, manufacturing method thereof, polarizing plate and liquid crystal display KONICA MINOLTA OPTO, INC. (JP) 2007-11-01 US disclosed
US-20070254115-A1 Polarizer protective film, manufacturing method thereof, polarizing plate and liquid crystal display KONICA MINOLTA OPTO, INC. (JP) 2007-11-01 US disclosed
US-20070224543-A1 Photopolymer Printing Plate Precursor AGFA-GEVAERT (BE) 2007-09-27 US disclosed
US-7247249-B2 Method of treating razor blade cutting edges THE GILLETTE COMPANY (US) 2007-07-24 US disclosed
US-20070128380-A1 Cellulose Ester Film, Its Manufacturing Method, Polarizing Plate, and Liquid Crystal Display KONICA MINOLTA OPTO, INC. (JP) 2007-06-07 US disclosed
US-20070128380-A1 Cellulose Ester Film, Its Manufacturing Method, Polarizing Plate, and Liquid Crystal Display KONICA MINOLTA OPTO, INC. (JP) 2007-06-07 US disclosed
US-20070092747-A1 Polyolefin resin composition, method of inhibiting generation of gel from the same, support for image recording material and method of producing the same FUJI PHOTO FILM CO., LTD. 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130041066-A1 HYDROPHILIZED CURABLE SILICONE IMPRESSION MATERIALS WITH IMPROVED STORAGE BEHAVIOR PIEZO1, IP6K1, IP6K2 TSHR 3484/4885KDM4E 2022/4885NR1I2 2856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.